Corrigendum: “Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages” (Pharmacological Reports (2014) 66(3) (594) (S1734114014001388) (10.1016/j.pharep.2013.11.008));Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages

Pharmacological Reports

Volumn 66, Issue 3, 2014, Pages 418-429

  Bułdak, Łukasz ^a   Łabuzek, Krzysztof ^a   Bułdak, Rafał Jakub ^a   Kozłowski, Michał ^a   MacHnik, Grzegorz ^a   Liber, Sebastian ^a   Suchy, Dariusz ^a   Duława Bułdak, Anna ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antioxidative enzymes; Macrophages; Metformin; Oxidative stress

Indexed keywords

ARGINASE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MANNOSE RECEPTOR; METFORMIN; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; ATHEROSCLEROSIS; DRUG EFFECTS; FEMALE; INFLAMMATION; MALE; METABOLISM; OXIDATIVE STRESS; PHENOTYPE;

AMP-ACTIVATED PROTEIN KINASES; ANTIOXIDANTS; ATHEROSCLEROSIS; CATALASE; CYTOKINES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MALONDIALDEHYDE; METFORMIN; MONOCYTES; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84901409110     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2017.02.010     Document Type: Erratum

References (37)

1. UKPDS Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 854 865
2. K. Isoda, J.L. Young, A. Zirlik, L.A. MacFarlane, N. Tsuboi, and N. Gerdes et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells Arterioscler Thromb Vasc Biol 26 2006 611 617
3. L. Li, J.C. Mamputu, N. Wiernsperger, and G. Renier Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin Diabetes 54 2005 2227 2234 (Pubitemid 40911288)
4. J.C. Mamputu, N.F. Wiernsperger, and G. Renier Antiatherogenic properties of metformin: the experimental evidence Diabetes Metab 29 4 Pt 2 2003 6S71-6
5. J.G. Park, and G.T. Oh The role of peroxidases in the pathogenesis of atherosclerosis BMB Rep 44 2011 497 505
6. F. Pattyn, F. Speleman, A. De Paepe, and J. Vandersompele RTPrimerDB: the Real-Time PCR primer and probe database Nucleic Acids Res 31 2003 122 123 (Pubitemid 36150349)
7. M.L. Hegde, T.K. Hazra, and S. Mitra Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells Cell Res 18 2008 27 47
8. R.J. Bułdak, R. Polaniak, L. Bułdak, K. Zwirska-Korczala, M. Skonieczna, and A. Monsiol et al. Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells Bioelectromagnetics 33 2012 641 651
9. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, and J. Fenyk-Melody et al. Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
10. M.C. Towler, and D.G. Hardie AMP-activated protein kinase in metabolic control and insulin signaling Circ Res 100 2007 328 341
11. K. Łabuzek, S. Liber, B. Gabryel, and B. Okopień Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures Pharmacol Rep 62 2010 827 848
12. S. Aquaro, C. Muscoli, A. Ranazzi, M. Pollicita, T. Granato, and L. Masuelli et al. The contribution of peroxynitrite generation in HIV replication in human primary macrophages Retrovirology 4 2007 76
13. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
14. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
15. B. Okopień, J. Kowalski, R. Krysiak, K. Łabuzek, A. Stachura-Kułach, and A. Kułach et al. Monocyte suppressing action of fenofibrate Pharmacol Rep 57 2005 367 372 (Pubitemid 41030697)
16. K. Labuzek, S. Liber, B. Gabryel, L. Bułdak, and B. Okopień Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures Naunyn Schmiedebergs Arch Pharmacol 381 2010 41 57
17. S.A. Kim, and H.C. Choi Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells Biochem Biophys Res Commun 425 2012 866 872
18. G.L. Kelly, A.E. Milner, G.S. Baldwin, A.I. Bell, and A.B. Rickinson Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells PNAS 103 2006 14935 14940 (Pubitemid 44527832)
19. P. Rice, I. Longden, and A. Bleasby EMBOSS: The European Molecular Biology Open Software Suite Trends Genet 16 2000 276 277
20. R. Medeiros, R.D. Prediger, G.F. Passos, P. Pandolfo, F.S. Duarte, and J.L. Franco et al. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein J Neurosci 27 2007 5394 5404 (Pubitemid 46790177)
21. C. Wilcock, N.D. Wyre, and C.J. Bailey Subcellular distribution of metformin in rat liver J Pharm Pharmacol 43 1991 442 444
22. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic Biol Med 30 2001 1191 1212 (Pubitemid 32463931)
23. R.J. Bułdak, L. Bułdak, R. Polaniak, M. Kukla, E. Birkner, and R. Kubina et al. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study Oncol Rep 29 2013 771 778
24. A. Esteghamati, D. Eskandari, H. Mirmiranpour, S. Noshad, M. Mousavizadeh, and M. Hedayati et al. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial Clin Nutr 32 2013 179 185
25. S.B. Ghatak, P.S. Dhamecha, S.V. Bhadada, and S.J. Panchal Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats Eur J Pharmacol 659 2011 213 223
26. W. Lu, M.A. Ogasawara, and P. Huang Models of reactive oxygen species in cancer Drug Discov Today Dis Models 4 2007 67 73
27. S. Krifka, K.A. Hiller, G. Spagnuolo, A. Jewett, G. Schmalz, and H. Schweikl The influence of glutathione on redox regulation by antioxidant proteins and apoptosis in macrophages exposed to 2-hydroxyethyl methacrylate (HEMA) Biomaterials 33 2012 5177 5186
28. H. Sies Biological redox systems and oxidative stress Cell Mol Life Sci 64 2007 2181 2188
29. D. Kukidome, T. Nishikawa, K. Sonoda, K. Imoto, K. Fujisawa, and M. Yano et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells Diabetes 55 2006 120 127 (Pubitemid 43343306)
30. C. Batandier, B. Guigas, D. Detaille, M.Y. El-Mir, E. Fontaine, and M. Rigoulet et al. The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin J Bioenerg Biomembr 38 2006 33 42 (Pubitemid 44078517)
31. M. Arai, M. Uchiba, H. Komura, Y. Mizuochi, N. Harada, and K. Okajima Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro J Pharmacol Exp Ther 334 2010 206 213
32. Y. Hattori, K. Suzuki, S. Hattori, and K. Kasai Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells Hypertension 47 2006 1183 1188 (Pubitemid 44289177)
33. K. Tsoyi, H.J. Jang, I.T. Nizamutdinova, Y.M. Kim, Y.S. Lee, and H.J. Kim et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice Br J Pharmacol 162 2011 1498 1508
34. L.A. Faine, M. Rudnicki, F.A. César, B.L. Heras, L. Boscá, and E.S. Souza et al. Anti-inflammatory and antioxidant properties of a new arylidene-thiazolidinedione in macrophages Curr Med Chem 18 2011 3351 3360
35. S. Wang, P. Song, and M.H. Zou AMP-activated protein kinase, stress responses and cardiovascular diseases Clin Sci (Lond) 122 2012 555 573
36. Z. Xie, Y. Dong, M. Zhang, M.Z. Cui, R.A. Cohen, and U. Riek et al. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells J Biol Chem 281 2006 6366 6375 (Pubitemid 43847568)
37. S.L. Choi, S.J. Kim, K.T. Lee, J. Kim, J. Mu, and M.J. Birnbaum et al. The regulation of AMP-activated protein kinase by H(2)O(2) Biochem Biophys Res Commun 287 2001 92 97 (Pubitemid 32912467)